Thursday 15 October 2026 Export ELDN’s income statement to Excel — free account

Eledon Pharmaceuticals, Inc.

ELDN Healthcare Biotechnology

In the quarter to June 2026, EPS fell 107.7% and free cash flow fell 28.0%, each against the same quarter a year earlier.

2.27 0.02 +0.89%

Follow ELDN

Alert me

Market cap: $190.2M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(143.22%)	(63.56%)	(150.79%)	(236.51%)
ROA Full definition →		(65.28%)	(26.34%)	(50.75%)	(72.74%)
ROIC Full definition →		0.00%	(1,511.24%)	0.00%	0.00%
Return on Tangible Assets Full definition →		(97.30%)	(38.87%)	(78.06%)	(121.23%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(0.87)	(0.76)	(0.61)	(0.65)
Free Cash Flow Full definition →		(67.24)	(62.34)	(68.89)	(73.86)
Other line items
Cash ROIC Full definition →		(36.45%)	(23.08%)	(32.57%)	(45.93%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.84	1.37	0.88	0.75
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.87)	(0.76)	(0.61)	(0.65)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Fold the line items

Columns are period end dates